JENNIFER OLSON: Open Payments
NPI 1932202991 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 10 payments from 7 companies in 2025. Trend: 2023 $599 · 2024 $371 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $50 |
| ABBVIE INC. | 2 | $41 |
| Abbott Laboratories | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: MOUNJARO, VRAYLAR, ETERNA, TRELEGY ELLIPTA, WaveWriter Alpha Prime 16, BREZTRI, QULIPTA, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
